Hallucinogens Tested as Treatment for Cancer Anxiety

Psychedelic Academe 1 Enlarge Image
close Psychedelic Academe 1

Twenty-one times now, a cancer patient suffering from anxiety has shown up early in the morning at Stephen Ross's New York University lab, clasped hands with two therapists, and taken a dose of psilocybin, the active ingredient in magic mushrooms. When the effects of the drug start to take hold, the patient lies down on a couch in the lab—which could pass for a living room—and is given eye shades and headphones playing music he or she has chosen in